Prescription opioids and economic hardship in France.


Journal

The European journal of health economics : HEPAC : health economics in prevention and care
ISSN: 1618-7601
Titre abrégé: Eur J Health Econ
Pays: Germany
ID NLM: 101134867

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 15 03 2022
accepted: 01 12 2022
medline: 6 10 2023
pubmed: 30 1 2023
entrez: 29 1 2023
Statut: ppublish

Résumé

This paper studies how opioid analgesic sales are empirically related to socioeconomic disparities in France, with a focus on poverty. This analysis is made possible using the OpenHealth database, which provides retail sales data for opioid analgesics available on the French market. We exploit firm-level data for each of the 94 departments in Metropolitan France between 2008 and 2017. We show that increases in the poverty rate are associated with increases in sales: a one percentage point increase in poverty is associated with approximately a 5% increase in mild opioid sales. Our analysis further shows that opioid sales are positively related to the share of middle-aged people and individuals with basic education only, while they are negatively related to population density. The granularity and longitudinal nature of these data allow us to control for a large pool of potential confounding factors. Our results suggest that additional interventions should be more intensively addressed toward the most deprived areas. We conclude that a combination of policies aimed at improving economic prospects and strictly monitoring access to opioid medications would be beneficial for reducing opioid-related harm.

Identifiants

pubmed: 36710287
doi: 10.1007/s10198-022-01557-4
pii: 10.1007/s10198-022-01557-4
pmc: PMC9884604
doi:

Substances chimiques

Analgesics, Opioid 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1473-1504

Subventions

Organisme : H2020 European Research Council
ID : 339950

Informations de copyright

© 2023. The Author(s).

Références

Brookings Pap Econ Act. 2017 Spring;2017:397-476
pubmed: 29033460
Proc Natl Acad Sci U S A. 2015 Dec 8;112(49):15078-83
pubmed: 26575631
JAMA Intern Med. 2020 Feb 1;180(2):254-262
pubmed: 31886844
J Health Econ. 2019 Dec;68:102243
pubmed: 31734583
N Engl J Med. 2008 Jun 5;358(23):2468-81
pubmed: 18525043
Can J Psychiatry. 1997 Apr;42(3):285-90
pubmed: 9114944
Int J Drug Policy. 2019 Feb;64:87-94
pubmed: 30641450
Eur J Surg Oncol. 2016 Jan;42(1):51-8
pubmed: 26490007
Curr Drug Abuse Rev. 2015;8(1):3-14
pubmed: 26084418
J Pain. 2012 Oct;13(10):988-96
pubmed: 23031398
JAMA. 2020 Oct 27;324(16):1615-1617
pubmed: 32945831
BMJ. 2019 Nov 5;367:l6015
pubmed: 31690553
Health Aff (Millwood). 2015 May;34(5):836-43
pubmed: 25941286
Gastroenterol Clin Biol. 2004 Apr;28(4):378-83
pubmed: 15146154
Eur J Health Econ. 2016 May;17(4):453-70
pubmed: 25951924
Soc Sci Med. 2001 May;52(9):1371-90
pubmed: 11286362
PLoS One. 2014 Oct 15;9(10):e106907
pubmed: 25330004
Age Ageing. 2017 Jul 1;46(4):607-613
pubmed: 28064169
Eur J Health Econ. 2021 Mar;22(2):311-327
pubmed: 33387139
N Engl J Med. 2018 Apr 26;378(17):1567-1569
pubmed: 29694805
JAMA Intern Med. 2018 Jun 1;178(6):861-863
pubmed: 29799955
Int J Epidemiol. 2015 Oct;44(5):1474-83
pubmed: 26613712
J Health Econ. 2019 Mar;64:25-42
pubmed: 30784811
Public Health. 2009 Jan;123(1):e29-34
pubmed: 19117581
Demography. 2019 Oct;56(5):1747-1764
pubmed: 31452094
Brookings Pap Econ Act. 2017 Fall;2017(2):1-87
pubmed: 30739945
Eur J Pain. 2019 Jan;23(1):124-134
pubmed: 30051548
Addict Behav. 2017 Nov;74:63-66
pubmed: 28582659
PLoS One. 2012;7(4):e34387
pubmed: 22509296
Am J Health Econ. 2018 Summer;4(3):383-410
pubmed: 30498764
Orthop Traumatol Surg Res. 2015 Feb;101(1):5-10
pubmed: 25583235
J Health Econ. 2017 Dec;56:222-233
pubmed: 29128677
Clinicoecon Outcomes Res. 2018 Jan 18;10:53-65
pubmed: 29403296
Pain Physician. 2013 Jan;16(1):89-100
pubmed: 23340537
JAMA Netw Open. 2019 Jan 4;2(1):e186007
pubmed: 30657529
Am J Public Health. 2022 Apr;112(S2):S128-S132
pubmed: 35349315
Neuropharmacology. 2021 May 1;188:108518
pubmed: 33716076
Eur J Health Econ. 2020 Dec;21(9):1391-1398
pubmed: 32748104
Soc Sci Med. 2015 Mar;128:316-26
pubmed: 25577953
Demography. 2022 Apr 1;59(2):607-628
pubmed: 35195250
Health Policy. 2014 Nov;118(2):215-21
pubmed: 25260910
Science. 2018 Aug 10;361(6402):588-590
pubmed: 30093595
Soc Sci Med. 2010 Apr;70(8):1176-84
pubmed: 20137844

Auteurs

Ilaria Natali (I)

Université Libre de Bruxelles, Avenue F. D. Roosevelt, 50, 1050, Brussels, Belgium. ilaria.natali@ulb.be.
European Center for Advanced Research in Economics and Statistics (ECARES), Université Libre de Bruxelles, Brussels, Belgium. ilaria.natali@ulb.be.
Institute for Interdisciplinary Innovation in Healthcare (I3h), Université Libre de Bruxelles, Brussels, Belgium. ilaria.natali@ulb.be.
Toulouse School of Economics (TSE), Université Toulouse 1 Capitole, Toulouse, France. ilaria.natali@ulb.be.

Mathias Dewatripont (M)

European Center for Advanced Research in Economics and Statistics (ECARES), Université Libre de Bruxelles, Brussels, Belgium.
Institute for Interdisciplinary Innovation in Healthcare (I3h), Université Libre de Bruxelles, Brussels, Belgium.

Victor Ginsburgh (V)

European Center for Advanced Research in Economics and Statistics (ECARES), Université Libre de Bruxelles, Brussels, Belgium.
Institute for Interdisciplinary Innovation in Healthcare (I3h), Université Libre de Bruxelles, Brussels, Belgium.

Michel Goldman (M)

Institute for Interdisciplinary Innovation in Healthcare (I3h), Université Libre de Bruxelles, Brussels, Belgium.

Patrick Legros (P)

European Center for Advanced Research in Economics and Statistics (ECARES), Université Libre de Bruxelles, Brussels, Belgium.
Institute for Interdisciplinary Innovation in Healthcare (I3h), Université Libre de Bruxelles, Brussels, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH